Interactive EMS Course
Acute Pulmonary Edema
Complete five clinical decisions covering recognition, respiratory support, CPAP, medication considerations, reassessment, and transport.
Format
Interactive Scenario
Decisions
Five Clinical Steps
Passing Score
80%
Course Preview
What You Will Practice
This scenario focuses on recognizing severe acute pulmonary edema, supporting oxygenation and ventilation, considering CPAP and protocol-directed medication, monitoring the patient's response, and continuing appropriate transport.
The course overview remains public. A free GrumpyMedic Education account is required to begin the interactive scenario.
Learning Objectives
What You Should Be Able to Do
By the end of this course, you should be able to recognize acute pulmonary edema, explain the underlying pathophysiology, perform a focused EMS assessment, understand the role of CPAP and nitroglycerin, identify important contraindications, and reassess the patient's response to treatment.
✓ Define acute pulmonary edema and describe why it causes severe respiratory distress.
✓ Explain how acute left ventricular failure can increase pulmonary capillary pressure.
✓ Recognize common symptoms and prehospital assessment findings.
✓ Identify immediate airway, oxygenation, ventilation, monitoring, and transport priorities.
✓ Explain how CPAP can improve oxygenation and reduce work of breathing.
✓ Explain why nitroglycerin may benefit selected patients with hypertensive pulmonary edema.
✓ Review the Massachusetts Protocol 6.10 Medical Director Option pathway presented in this course.
✓ Recognize improvement, treatment failure, and signs of impending respiratory failure.
Section 1
What Is Acute Pulmonary Edema?
Acute pulmonary edema is a rapid accumulation of fluid within the pulmonary interstitium and alveoli. In cardiogenic pulmonary edema, the problem commonly begins when the left ventricle is unable to effectively move blood forward.
When left ventricular function deteriorates, pressure can back up into the left atrium and pulmonary veins. As pulmonary capillary hydrostatic pressure rises, fluid is forced from the vascular space into the lung interstitium and eventually the alveoli.
Fluid occupying alveolar spaces interferes with normal gas exchange. The patient may rapidly develop hypoxia, tachypnea, increased work of breathing, anxiety, diaphoresis, and severe respiratory distress.
Think Through the Physiology
Section 2
Clinical Presentation
Pulmonary edema should be recognized from the overall clinical picture rather than a single finding. The presentation may evolve rapidly, and the patient may not have every classic sign.
Common Symptoms and Presentation
- • Sudden or severe dyspnea
- • Orthopnea or inability to tolerate lying flat
- • Tachypnea
- • Anxiety and a sense of air hunger
- • Diaphoresis
- • Hypoxia or cyanosis
- • Possible pink, frothy sputum
Focused EMS Assessment Findings
- • Patent airway with markedly labored breathing
- • Accessory muscle use and increased work of breathing
- • SpO₂ may be below 94%
- • Diffuse crackles may be present
- • Elevated blood pressure is common in hypertensive APE
- • JVD or peripheral edema may be present
- • Cardiac monitoring may reveal ischemia or dysrhythmia
GrumpyMedic Pearl
Do not wait for pink frothy sputum before considering pulmonary edema. Severe dyspnea, orthopnea, hypoxia, crackles, marked hypertension, and increased work of breathing may already provide a strong clinical picture.
Section 3
Initial Prehospital Management
Management should occur while the assessment continues. The patient's airway, breathing, oxygenation, blood pressure, and mental status can change quickly.
1. Positioning
Allow the patient to remain upright when tolerated. Patients with orthopnea may become significantly more distressed when placed flat.
2. Airway and Oxygenation
Assess airway patency, respiratory effort, oxygen saturation, and the patient's ability to speak. Provide oxygen and ventilatory support according to clinical need and protocol.
3. Positive Pressure
Consider CPAP/BiPAP early in an appropriate patient who is still able to maintain the airway and tolerate the interface.
4. Cardiac and BP Monitoring
Obtain frequent blood-pressure measurements and continuous cardiac monitoring. Consider a 12-lead ECG when indicated and feasible.
5. Vascular Access
Establish IV or IO access when appropriate without delaying critical airway and respiratory interventions.
6. Medication and Reassessment
Use protocol-directed medications, reassess frequently, and transport promptly while continuing effective treatment.
Section 4
CPAP: Why It Matters
CPAP provides continuous positive airway pressure throughout the respiratory cycle. In an appropriate patient with acute pulmonary edema, this can improve oxygenation and reduce the work required to breathe.
Positive pressure can help recruit poorly ventilated alveoli, improve ventilation and oxygenation, and reduce venous return to the heart. That reduction in preload may be beneficial when pulmonary vascular pressure is contributing to pulmonary edema.
Reassess After CPAP
Section 5
Nitroglycerin in Acute Pulmonary Edema
Nitroglycerin produces vasodilation. In selected patients with hypertensive pulmonary edema, reducing venous return can lower preload and pulmonary capillary pressure. At greater vasodilatory effect, afterload and cardiac workload may also be reduced.
Nitroglycerin does not directly remove fluid from the body. Instead, its hemodynamic effects can reduce the pressure driving fluid into the lungs and improve symptoms of pulmonary congestion while other supportive care continues.
Because blood pressure can change rapidly, frequent reassessment is essential. Medication use must follow the current protocol, service policy, medical direction, and patient-specific contraindications.
Why It May Help
- • Vasodilation can decrease preload
- • Pulmonary capillary pressure may decrease
- • Cardiac workload may decrease
- • Pulmonary congestion symptoms may improve
What Must Be Watched
- • Blood pressure trend
- • Mental status and perfusion
- • Respiratory response
- • Contraindications and medication history
Section 6 — Massachusetts Protocol Focus
Protocol 6.10 Medical Director Option
The course source material reviews the June 1, 2026 Massachusetts Protocol 6.10 Medical Director Option for IV/IO nitroglycerin and infusion in acute pulmonary edema. This section is protocol-specific and should be used only by appropriately authorized providers operating under the current protocol and service medical direction.
Patient Profile Presented in the Course Material
- • Acute pulmonary edema treated with CPAP/BiPAP
- • CHF history with respiratory distress may be present
- • Findings may include edema, rales/crackles, and dyspnea
- • Room-air SpO₂ may be below 94%
Contraindication / Consultation Points in the Source Material
- • SBP below 160 mmHg is presented as requiring medical-control consultation for this option.
- • Phosphodiesterase inhibitor use within 48 hours is listed as a contraindication.
Prior Nitroglycerin Given
- • SBP ≥160 mmHg
- • Start infusion at 100 mcg/min
- • Titrate by 25 mcg/min every 3–5 minutes
- • Maximum 300 mcg/min
- • Maintain SBP ≥120 mmHg
No Prior Nitroglycerin
- • SBP ≥160 mmHg
- • Give 400 mcg IV bolus
- • Start infusion at 100 mcg/min
- • Titrate by 25 mcg/min every 3–5 minutes
- • Maximum 300 mcg/min
Medical-Control Pathway
- • SBP 120–159 mmHg
- • Start infusion at 50 mcg/min
- • Titrate by 25 mcg/min every 3–5 minutes
- • Maximum 300 mcg/min
Protocol Safety Notice
Verify the current Massachusetts EMS protocol before clinical use. Providers must follow current state and local protocols, medical-director authorization, medical control, service policy, and manufacturer instructions. This educational course does not replace the official protocol.
Section 7
Reassessment: Is the Patient Improving?
Treatment is not complete when CPAP is applied or medication is given. Reassessment determines whether the patient is responding, remaining stable, or progressing toward respiratory failure.
Signs of Improvement
- • SpO₂ improves
- • Respiratory rate trends downward
- • Accessory muscle use decreases
- • Patient can speak in longer sentences
- • Anxiety and visible distress decrease
- • Blood pressure improves without hypotension
Signs of Deterioration
- • Altered mental status
- • Increasing fatigue
- • Persistent or worsening hypoxia
- • Decreasing respiratory effort despite severe distress
- • Inability to tolerate or protect the airway with CPAP
- • Falling blood pressure or worsening perfusion
Clinical Summary
Recognize early. Treat rapidly. Reassess continuously.
Severe dyspnea, diffuse crackles, hypoxia, and hypertension should raise concern for acute pulmonary edema. Support oxygenation and ventilation, consider CPAP and protocol-directed nitroglycerin when appropriate, and continually reassess blood pressure, SpO₂, respiratory effort, and mental status.
Formative Review
Stop & Think
These questions are for learning and do not replace the secure end-of-course assessment. Think through each answer before opening the explanation.
1. A 74-year-old patient is sitting upright, RR 34, SpO₂ 84%, BP 202/116, with diffuse crackles and severe work of breathing. What findings make early CPAP particularly important to consider?
2. Why can nitroglycerin improve pulmonary edema even though it does not directly remove fluid from the body?
3. A patient's SpO₂ rises after CPAP, but the patient becomes drowsy and respiratory effort decreases. Is this automatically an improvement?
Next: Clinical Application
Apply What You Learned
The five-decision scenario below applies the course material to a deteriorating patient with severe respiratory distress. Your official course timer must reach the required duration before the scenario and assessment pathway unlock.
Checking Course Access
Verifying your student account.